Biohaven Pharmaceutical Holding (BHVN) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…
Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

The launch of spot Bitcoin (CRYPTO: BTC) exchange-traded funds (ETFs) in January 2025 marked a turning point in the cryptocurrency market. These ETFs…
Advanced Charting Tools For Traders

January 1, 2025 Advanced Charting Tools For Traders

Ever tried deciphering market trends with the intensity of a detective peering over cryptic clues? Enter the realm of Advanced Charting, where complex…
Why Is Trading Important?

December 21, 2024 Why Is Trading Important?

Trade isn’t just figures on a spreadsheet; it’s the pulse of our global community. In 2018, the United States faced a staggering $621…

Biohaven Pharmaceutical Holding (BHVN) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: February 10, 2025 (07:56)

Sector: Healthcare

The share price of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) now

Latest session on the 7th of February for
Biohaven Pharmaceutical Holding Company Ltd. is negative
Trading Volume: 546119
Open: 38.87 /  High: 39.44 /  Low: 38.03
Current value: $38.43
What analysts predict: $65.14
52-week High/Low: $62.21 / $26.8
50-Day Moving Average: $39.75 — resistance level today
200-Day Moving Average: $40.77 — resistance level today

Are you interested in Biohaven Pharmaceutical Holding Company Ltd. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Biohaven Pharmaceutical Holding stock price in 2025, 2026, 2027. How much will one Biohaven Pharmaceutical Holding share be worth in 2025 - 2027?

When should I take profit in Biohaven Pharmaceutical Holding stock? When should I record a loss on Biohaven Pharmaceutical Holding stock? What are analysts' forecasts for Biohaven Pharmaceutical Holding stock? What is the future of Biohaven Pharmaceutical Holding stock? We forecast Biohaven Pharmaceutical Holding stock performance using neural networks based on historical data on Biohaven Pharmaceutical Holding stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Biohaven Pharmaceutical Holding stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Biohaven Pharmaceutical Holding shares. This happens once a day.


Historical and forecast chart of Biohaven Pharmaceutical Holding stock

The chart below shows the historical price of Biohaven Pharmaceutical Holding stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Biohaven Pharmaceutical Holding stock price can be found in the table below.

Long-term forecasts by years.

Biohaven Pharmaceutical Holding Company Ltd., a clinical stage biopharmaceutical company, is developing advanced candidate products targeting neurological diseases and rare disorders in the United States. Its clinical stage products include Rimehepant, a product that has completed phase III trials for the acute treatment and prevention of migraines; Vasegepant, which has completed phase 2/3 trials for acute treatment and prevention of migraine; and Troriluzole, which has completed phase II / III randomization and is continuing with extended trials for ataxia. The company also offers Troril uzole, which is a phase II / III clinical stage for obsessive-compulsive disorder and Alzheimer’s disease; BHV-0223, product for amyotrophic lateral sclerosis; BHV-5000, a product that has completed phase I clinical trials for neuropsychiatric disorders; and Verdiperstat, a product that is in phase III clinical trials for multiple systemic atrophy. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine assessment of migraine sufferers. The company was founded in 2013 and is headquartered in New Haven, Connecticut.

Trending Themes in the Healthcare Sector

Biohaven Pharmaceutical Holding daily forecast for a month

Date Target Pes. Opt. Vol., %
Feb 12 38.60 37.84 38.85 2.66
Feb 13 38.47 38.00 39.01 2.64
Feb 14 38.15 37.81 38.53 1.91
Feb 15 37.92 37.23 38.48 3.36
Feb 16 38.80 37.90 39.45 4.08
Feb 17 38.23 37.84 38.92 2.85
Feb 18 38.27 37.81 38.91 2.88
Feb 19 38.80 38.42 39.43 2.64
Feb 20 39.48 39.15 40.02 2.24
Feb 21 39.94 39.59 40.90 3.30
Feb 22 38.87 38.17 39.46 3.36
Feb 23 39.01 38.10 39.88 4.67
Feb 24 39.05 38.39 39.74 3.51
Feb 25 40.17 39.92 40.47 1.39
Feb 26 40.46 40.18 41.18 2.48
Feb 27 41.66 40.96 41.93 2.35
Feb 28 42.18 41.68 42.61 2.22
Mar 01 42.19 41.64 42.67 2.46
Mar 02 42.04 41.48 42.78 3.13
Mar 03 41.46 40.59 41.97 3.40
Mar 04 41.51 41.13 42.48 3.27
Mar 05 41.24 40.58 41.60 2.53
Mar 06 40.68 40.42 41.02 1.48
Mar 07 41.25 40.52 42.05 3.79
Mar 08 41.79 40.85 42.40 3.77
Mar 09 41.56 40.71 42.30 3.92
Mar 10 40.93 40.32 41.60 3.17
Mar 11 40.78 40.32 41.10 1.94
Mar 12 39.77 39.44 40.48 2.66
Mar 13 38.60 38.11 39.38 3.31

Biohaven Pharmaceutical Holding Daily Price Targets


Biohaven Pharmaceutical Holding Stock Forecast 02-12-2025.

Forecast target price for 02-12-2025: $38.60.
Positive dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 2.594%.
Pessimistic target level: 37.84
Optimistic target level: 38.85

Biohaven Pharmaceutical Holding Stock Forecast 02-13-2025.

Forecast target price for 02-13-2025: $38.47.
Negative dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 2.575%.
Pessimistic target level: 38.00
Optimistic target level: 39.01

Biohaven Pharmaceutical Holding Stock Forecast 02-14-2025.

Forecast target price for 02-14-2025: $38.15.
Negative dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 1.871%.
Pessimistic target level: 37.81
Optimistic target level: 38.53

Biohaven Pharmaceutical Holding Stock Forecast 02-15-2025.

Forecast target price for 02-15-2025: $37.92.
Negative dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 3.252%.
Pessimistic target level: 37.23
Optimistic target level: 38.48

Biohaven Pharmaceutical Holding Stock Forecast 02-16-2025.

Forecast target price for 02-16-2025: $38.80.
Positive dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 3.924%.
Pessimistic target level: 37.90
Optimistic target level: 39.45

Biohaven Pharmaceutical Holding Stock Forecast 02-17-2025.

Forecast target price for 02-17-2025: $38.23.
Negative dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 2.770%.
Pessimistic target level: 37.84
Optimistic target level: 38.92

BHVN (BHVN) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Mar. 37.29 34.29 40.28 14.87
Apr. 39.09 38.15 40.77 6.43
May. 39.05 37.98 41.71 8.96
Jun. 40.04 39.16 43.52 10.02
Jul. 37.13 34.27 39.58 13.41
Aug. 41.05 39.61 43.72 9.40
Sep. 45.07 42.00 48.24 12.95
Oct. 42.69 39.97 45.65 12.45
Nov. 44.01 42.85 46.23 7.33
Dec. 47.30 45.37 48.60 6.64

Biohaven Pharmaceutical Holding forecast for this year


Biohaven Pharmaceutical Holding Stock Prediction for Mar 2025

An downtrend is forecast for this month with an optimal target price of $37.2886. Pessimistic: $34.29. Optimistic: $40.28


Biohaven Pharmaceutical Holding Stock Prediction for Apr 2025

An uptrend is forecast for this month with an optimal target price of $39.0934. Pessimistic: $38.15. Optimistic: $40.77


Biohaven Pharmaceutical Holding Stock Prediction for May 2025

An downtrend is forecast for this month with an optimal target price of $39.0504. Pessimistic: $37.98. Optimistic: $41.71


Biohaven Pharmaceutical Holding Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $40.0384. Pessimistic: $39.16. Optimistic: $43.52


Biohaven Pharmaceutical Holding Stock Prediction for Jul 2025

An downtrend is forecast for this month with an optimal target price of $37.1316. Pessimistic: $34.27. Optimistic: $39.58


Biohaven Pharmaceutical Holding Stock Prediction for Aug 2025

An uptrend is forecast for this month with an optimal target price of $41.0527. Pessimistic: $39.61. Optimistic: $43.72


Biohaven Pharmaceutical Holding Stock Prediction for Sep 2025

An uptrend is forecast for this month with an optimal target price of $45.0717. Pessimistic: $42.00. Optimistic: $48.24


Biohaven Pharmaceutical Holding Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $42.692. Pessimistic: $39.97. Optimistic: $45.65


Biohaven Pharmaceutical Holding Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $44.0069. Pessimistic: $42.85. Optimistic: $46.23


Biohaven Pharmaceutical Holding Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $47.2986. Pessimistic: $45.37. Optimistic: $48.60



Biohaven Pharmaceutical Holding (BHVN) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 44.28 42.82 46.62 8.15
Feb 39.75 37.30 41.46 10.02
Mar 37.70 35.75 38.57 7.31
Apr 36.78 35.25 38.24 7.83
May 34.96 33.19 37.04 10.38
Jun 34.89 32.01 36.73 12.85
Jul 36.96 34.44 38.14 9.70
Aug 39.19 37.56 41.44 9.36
Sep 42.60 40.82 44.47 8.22
Oct 40.16 37.82 42.99 12.02
Nov 37.56 35.82 39.04 8.25
Dec 35.82 34.99 37.16 5.83

Biohaven Pharmaceutical Holding (BHVN) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 32.20 29.79 34.22 12.94
Feb 34.04 32.43 35.42 8.46
Mar 33.33 31.64 35.64 11.21
Apr 36.19 33.32 38.46 13.35
May 38.77 37.92 41.89 9.47
Jun 35.57 32.68 38.35 14.79
Jul 32.72 30.09 34.95 13.90
Aug 34.52 31.48 35.39 11.05
Sep 33.00 30.64 35.03 12.54
Oct 32.49 31.10 33.31 6.65
Nov 31.42 29.07 33.32 12.76
Dec 29.93 27.50 31.84 13.65

Biohaven Pharmaceutical Holding information and performance

Biohaven Pharmaceutical Holding Address

C/O BIOHAVEN PHARMACEUTICALS, INC., 215 CHURCH STREET, NEW HAVEN, CT, UNITED STATES

Market Capitalization: 3 931 620 000 $

Market capitalization of the Biohaven Pharmaceutical Holding Company Ltd. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BHVN shares in the company outstanding by the market price of one share.

EBITDA: -841 603 008 $

EBITDA of Biohaven Pharmaceutical Holding is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -9.26

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -2.188

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 101122000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Biohaven Pharmaceutical Holding Stock)

Should I Buy Biohaven Pharmaceutical Holding Shares in 2025 year?

The maximum forecasted share price for next year is $44.28, which is $5.85 higher than the current stock price. By investing in Biohaven Pharmaceutical Holding shares today for a one-year period, you could achieve a profit of 15.22%. With an investment horizon of up to two years, the target share price is $38.77. resulting in a profit of 0.89% ($0.34 per share).

Does Biohaven Pharmaceutical Holding pay dividends?

No, it does not

Which economic sector do Biohaven Pharmaceutical Holding's shares belong to?

Biohaven Pharmaceutical Holding's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Biohaven Pharmaceutical Holding's shares?

You can view all the stocks that are part of the same sector as Biohaven Pharmaceutical Holding's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.